- Home
- IQ vs CNTA Comparison
IQ vs CNTA Comparison
Compare IQ & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQ
- CNTA
- Stock Information
- Founded
- IQ 2009
- CNTA 2020
- Country
- IQ China
- CNTA United Kingdom
- Employees
- IQ N/A
- CNTA N/A
- Industry
- IQ Consumer Electronics/Video Chains
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- IQ Consumer Discretionary
- CNTA Health Care
- Exchange
- IQ Nasdaq
- CNTA Nasdaq
- Market Cap
- IQ 1.6B
- CNTA 1.9B
- IPO Year
- IQ 2018
- CNTA 2021
- Fundamental
- Price
- IQ $1.98
- CNTA $15.69
- Analyst Decision
- IQ Hold
- CNTA Strong Buy
- Analyst Count
- IQ 5
- CNTA 10
- Target Price
- IQ $2.60
- CNTA $28.78
- AVG Volume (30 Days)
- IQ 18.6M
- CNTA 984.4K
- Earning Date
- IQ 08-21-2025
- CNTA 08-12-2025
- Dividend Yield
- IQ N/A
- CNTA N/A
- EPS Growth
- IQ N/A
- CNTA N/A
- EPS
- IQ 0.04
- CNTA N/A
- Revenue
- IQ $3,925,356,854.00
- CNTA $15,000,000.00
- Revenue This Year
- IQ $2.04
- CNTA N/A
- Revenue Next Year
- IQ $3.29
- CNTA N/A
- P/E Ratio
- IQ $48.87
- CNTA N/A
- Revenue Growth
- IQ N/A
- CNTA 118.88
- 52 Week Low
- IQ $1.50
- CNTA $9.00
- 52 Week High
- IQ $3.76
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- IQ 73.98
- CNTA 68.00
- Support Level
- IQ $1.77
- CNTA $13.22
- Resistance Level
- IQ $1.92
- CNTA $15.48
- Average True Range (ATR)
- IQ 0.08
- CNTA 0.70
- MACD
- IQ 0.02
- CNTA 0.21
- Stochastic Oscillator
- IQ 90.54
- CNTA 86.44
About IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.